Theracryf Plc (AIM:TCF)
London · Delayed Price · Currency is GBP · Price in GBX 0.2150
0.00 (0.00%)
Jul 6, 2026, 1:27 PM GMT
Theracryf Market Cap
Theracryf has a market cap or net worth of 4.62 million as of July 6, 2026. Its market cap has decreased by -14.92% in one year.
Market Cap
4.62M
Enterprise Value
1.12M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.22
Market Cap Chart
Since October 21, 2015, Theracryf's market cap has decreased from 25.60M to 4.62M, a decrease of -81.95%. That is a compound annual growth rate of -14.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 4.62M | 7.50% |
| Dec 31, 2025 | 4.30M | 90.55% |
| Dec 31, 2024 | 2.26M | -48.72% |
| Dec 29, 2023 | 4.40M | -64.04% |
| Dec 30, 2022 | 12.23M | -13.59% |
| Dec 31, 2021 | 14.16M | -0.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 14.43M |
| Fusion Antibodies | 14.38M |
| Genflow Biosciences | 11.47M |
| Cizzle Biotechnology Holdings | 10.62M |
| OptiBiotix Health | 6.66M |
| CRISM Therapeutics | 5.83M |
| Thalia Therapeutics | 5.41M |
| Oxford BioDynamics | 4.72M |